Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Tempus AI, Inc. - Class A Common Stock
(NQ:
TEM
)
51.98
+5.86 (+12.71%)
Streaming Delayed Price
Updated: 3:30 PM EDT, Aug 7, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,897,897
Open
47.55
Bid (Size)
51.99 (100)
Ask (Size)
52.02 (200)
Prev. Close
46.12
Today's Range
47.23 - 52.17
52wk Range
40.77 - 104.32
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Is Tempus AI Stock Surging on Friday?
↗
Today 14:21 EDT
Tempus AI Inc. (NASDAQ: TEM) stock jumped on Friday, August 7, 2026, following strong AI healthcare peer earnings from Doximity Inc. and a strategic lab expansion with CellCarta.
Via
Benzinga
Topics
Artificial Intelligence
Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic Applications
August 04, 2026
From
Tempus AI, Inc.
Via
Business Wire
Performance
YTD
-16.6%
-16.6%
1 Month
-13.5%
-13.5%
3 Month
+5.1%
+5.1%
6 Month
-0.9%
-0.9%
1 Year
-6.4%
-6.4%
More News
Read More
Tempus AI Q2 Earnings Call Highlights
↗
July 31, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Earnings
Tempus AI Stock Slides Friday: What's Driving the Post-Earnings Reset?
↗
July 31, 2026
Via
Benzinga
Topics
Artificial Intelligence
Tempus AI (NASDAQ:TEM) Delivers Mixed Q2 Results with EPS Beat, Stock Slips in After-Hours Trading
↗
July 30, 2026
Via
Chartmill
Topics
Artificial Intelligence
Is Tempus AI Stock a Buy After Its CEO Sold 250,000 Shares?
↗
July 31, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Regulatory Compliance
Tempus Reports Second Quarter 2026 Results
July 30, 2026
From
Tempus AI, Inc.
Via
Business Wire
3 Powerful AI Stocks Poised for the Next Massive Shift
↗
July 28, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Tempus Announces National Launch of OneOme Pharmacogenomics Testing, Advancing Patient Safety and Precision Medicine
July 22, 2026
From
Tempus AI, Inc
Via
Business Wire
Tempus AI Bets on MRD Testing Growth With Personalis Acquisition
↗
July 20, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Tempus Highlights Landmark Publication Demonstrating Safe, Real-World Deployment of Paige Prostate AI Suite in the UK National Health Service
July 16, 2026
From
Tempus
Via
Business Wire
Tempus to Report Second Quarter 2026 Financial Results on July 30
July 09, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Announces Research Collaboration with Angiosarcoma Awareness, Inc. to Uncover Insights on Rare Cancers
June 25, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Announces Multi-Center Validation of AI-Enabled ECG Model for Predicting Atrial Fibrillation Risk Published in Heart Rhythm
June 11, 2026
From
Tempus AI, Inc.
Via
Business Wire
Genetics in Medicine Open Study Demonstrates How Ambry Genetics’ ExomeReveal® RNA Testing Can Improve Diagnostic Clarity in Exome Testing
June 09, 2026
From
Ambry Genetics
Via
Business Wire
Great News: This Explosive Healthcare Stock Could Be a Powerful Artificial Intelligence Winner
↗
June 08, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Tempus to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
June 05, 2026
From
Tempus AI, Inc.
Via
Business Wire
Why Tempus AI Stock Is Surging On Thursday?
↗
June 04, 2026
Via
Benzinga
Topics
Artificial Intelligence
Tempus Launches Open-Source Digital Pathology Consortium, Names Yale New Haven Health and Leading Cancer Center as Founding Members
June 03, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Announces the Upcoming Clinical Availability of Its First Whole-Genome Sequencing Assay, xH
June 01, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Unveils the Next-Generation of Lens, Expanding its Agentic AI Platform for Oncology Drug Development
May 31, 2026
From
Tempus AI, Inc.
Via
Business Wire
What to Know About This Fund's $32.6 Million Porch Group Purchase
↗
May 30, 2026
Via
The Motley Fool
Topics
Regulatory Compliance
Tempus Launches the PRECISION Challenge, a National Program Opening Its Foundation Model Work to the Broader Research Community
May 30, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Introduces ‘Preview’: Bridging the Critical Time Gap Between Diagnostic Order and Definitive Results
May 30, 2026
From
Tempus AI, Inc.
Via
Business Wire
Tempus Announces Initial Results from its Multimodal Foundation Model Efforts for Novel and Scalable Insight Generation in Oncology
May 29, 2026
From
Tempus AI, Inc.
Via
Business Wire
Frequently Asked Questions
Is Tempus AI, Inc. - Class A Common Stock publicly traded?
Yes, Tempus AI, Inc. - Class A Common Stock is publicly traded.
What exchange does Tempus AI, Inc. - Class A Common Stock trade on?
Tempus AI, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Tempus AI, Inc. - Class A Common Stock?
The ticker symbol for Tempus AI, Inc. - Class A Common Stock is TEM on the Nasdaq Stock Market
What is the current price of Tempus AI, Inc. - Class A Common Stock?
The current price of Tempus AI, Inc. - Class A Common Stock is 51.98
When was Tempus AI, Inc. - Class A Common Stock last traded?
The last trade of Tempus AI, Inc. - Class A Common Stock was at 08/07/26 03:30 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
